N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2 Purity ≥99.0% Argatroban Intermediate
Olupese Ipese Argatroban Awọn agbedemeji ibatan:
Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
| Orukọ Kemikali | N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester |
| Awọn itumọ ọrọ sisọ | Argatroban Intermediate-5 |
| Nọmba CAS | 74874-09-2 |
| NỌMBA CAT | RF-PI268 |
| Iṣura Ipo | Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn ọgọọgọrun Kilogram |
| Fọọmu Molecular | C25H35N7O7S |
| Òṣuwọn Molikula | 577.65 |
| Sowo Ipò | Sowo Labẹ Ibaramu otutu |
| Brand | Ruifu Kemikali |
| Nkan | Awọn pato |
| Ifarahan | Funfun tabi Pa-White Crystalline Powder |
| Mimo | ≥99.0% |
| Ohun elo ti o jọmọ | ≤2.0% |
| Enantiomorph | ≤0.30% |
| Awọn ohun elo ti o ku | |
| kẹmika kẹmika | ≤0.30% |
| Ethanol | ≤0.50% |
| Dichloromethane | ≤0.03% |
| Acetic Eteri | ≤0.50% |
| Triethylamine | ≤0.03% |
| Toluene | ≤0.10% |
| Awọn Irin Eru | ≤20ppm |
| Pipadanu lori Gbigbe | ≤0.50% |
| Aloku lori Iginisonu | ≤0.20% |
| Igbeyewo Standard | Standard Enterprise |
| Lilo | Argatroban Intermediate-5 |
Package: Igo, apo apamọwọ Aluminiomu, Ilu paali, 25kg / Drum, tabi gẹgẹbi ibeere alabara.
Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina, ọrinrin ati kokoro infestation.
Shanghai Ruifu Chemical Co., Ltd jẹ olupilẹṣẹ asiwaju ati olupese ti Argatroban Intermediate-5, N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester (CAS: 74874-09-2) pẹlu didara to gaju,jẹ agbedemeji ti Argatroban Monohydrate (CAS 141396-28-3) tabi Argatroban Anhydrous (CAS 74863-84-6).
Argatroban jẹ aṣoju antithrombotic sintetiki tuntun ti o wulo ni itọju anticoagulation wọn ọpọlọ ischemic ati itankale coagulation inu iṣan.Argatroban jẹ oogun apakokoro ti o ṣiṣẹ bi agbara, yiyan, oludena taara univalent ti thrombin.Argatroban ti fọwọsi ni ọdun 2000 fun prophylaxis tabi itọju ti thrombosis ni awọn alaisan ti o ni heparin-induced thrombocytopenia (HIT).
